Hexa Reports
This presentation is the property of its rightful owner.
Sponsored Links
1 / 4

Biochip Market Insights, Analysis And Segment Forecasts To 2024: Hexa Repor... PowerPoint PPT Presentation


Global biochips anticipated market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements in the biochips market along with high market demand from proteomic and genomic applications is expected to drive market growth.

Download Presentation

Biochip Market Insights, Analysis And Segment Forecasts To 2...

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Biochip market insights analysis and segment forecasts to 2024 hexa reports

Hexa Reports

Market Research Reports and Insightful Company Profiles

Biochip Market Analysis, Share and Size, Trends, Industry

Growth, Overview And Segment Forecasts To 2024

Global biochips anticipated market to reach USD 25.84 billion by 2024, according to a new report by

Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological

advancements in the biochips market along with high market demand from proteomic and genomic

applications is expected to drive market growth.

Anticipated launch and commercialization of novel products for diagnosis and treatment including

laboratory- and non-laboratory-based research are expected to further reinforce growth in demand.

Improvements in accuracy, resolution, and preparation procedures for the technology coupled with

reduction in costs of associated materials are expected to fuel growth over the forecast period.

Browse Detail Report With TOC @ http://www.hexareports.com/report/biochip-market/details

Ongoing developments related to further miniaturization of biochips are expected to enhance their

applicability and additional usage for genetic sequencing methodologies, such as cancer genomics. Their

usage is also expected to aid reduction in the cost of genome profiling, which is a factor likely to drive

demand for the next step of genetic analysis, i.e., protein expression analysis. Consequently, a growth in

the number of such protein profiling studies is expected to directly fuel demand for genomic and

proteomic labeling techniques through to 2024.

Further key findings from the report suggest:

DNA chips form the largest revenue-generating segment of the biochip applications. Major contribution

to this share comes from usage in cancer diagnostics/treatment and drug discovery applications. DNA


Biochip market insights analysis and segment forecasts to 2024 hexa reports

Hexa Reports

Market Research Reports and Insightful Company Profiles

chips accounted for around a third of the global market revenue in 2015. The other notable contributing

segments to application of biochips include gene expression, single nucleotide polymorphism

genotyping, genomic studies, and agricultural biotechnology.

The market is expected to have a high potential for growth as the technology has numerous applications

to aid the miniaturization of molecular biology and biochemical & chemical assays. Over time, such

miniaturization is expected to benefit medical technologies in terms of cost and input requirements.

DNA chips, lab-on-a-chip, protein chips, and tissue & cell arrays find a number of uses in pharmaceutical

& biotechnology companies, academic & research institutes, hospitals & diagnostic centers, and other

end users like point-of-care settings, forensic labs, blood banks, etc.

Biotechnology Market Research Related Reports:

Preimplantation Genetic Diagnosis (PGD) Market Analysis And Segment Forecasts To 2024 -

http://www.hexareports.com/report/preimplantation-genetic-diagnosis-market/details

Next Generation Sequencing (NGS) Data Analysis Market Analysis And Segment Forecasts To 2024

- http://www.hexareports.com/report/next-generation-sequencing-ngs-data-analysis-

market/details

North America was the largest revenue-generating region and accounted for over 45%of total revenue

in 2015. This can be attributed to by the presence of government initiatives for personalized patient

care coupled with the availability of a very large installed base of genetic and proteomic profiling

platforms across the U.S. High market usage of next-gen sequencing techniques for molecular diagnosis

and treatment used with microfluidic techniques also add to the large share. Furthermore, cancer

analysis projects in a number of academic and clinical research institutes are also responsible for the

region's large share.

Some key players operating in this industry include Abbott Laboratories; PerkinElmer, Inc.; GE

Healthcare; Illumina, Inc.; Thermo Fisher Scientific, Inc.; Merck Millipore; Agilent Technologies, Inc.;

Sigma-Aldrich Corporation; Fluidigm Corporation; and Bio-Rad Laboratories, Inc.

Table Of Content

Chapter 1 Methodology and Scope

1.1 Research Methodology

1.2 Research Scope & Assumptions

1.3 List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Biochip Industry Outlook

3.1 Market Segmentation

3.2 Market Size and Growth prospects, 2013 - 2024


Biochip market insights analysis and segment forecasts to 2024 hexa reports

Hexa Reports

Market Research Reports and Insightful Company Profiles

3.3 Biochip Market Dynamics

3.4 Key Opportunities Prioritized,2015

3.6 Industry Analysis - Porter's

3.7 Biochip PESTEL Analysis

Chapter 4 Biochip Type Outlook

4.1 Global Biochip Revenue Share, by Product, 2015 & 2024

4.2 DNA Chips, by Application

4.3 Lab-On-a-Chip, by Application

4.4 Protein Chips, by Application

4.5 Others

Chapter 5 Biochip End-Use Outlook

5.1 Global Biochip Revenue Share by End Use, 2015 & 2024

5.2 Biotechnology and Pharmaceutical Companies

5.3 Hospitals and Diagnostics Centers

5.4 Academic & Research Institutes

5.5 Others

Chapter 7 Biochip Regional Outlook

7.1 Global Biochip Revenue Share, By Region, 2015&2024

7.2 North America

7.3 Europe

7.4 Asia Pacific

7.5 Latin America

7.6 MEA

Chapter 8 Competitive Landscape

8.1 Abbott Laboratories

8.2 Agilent Technologies, Inc.

8.3 PerkinElmer, Inc.

8.4 Fluidigm Corporation

8.5 Illumina, Inc.

8.6 GE Healthcare

8.7 Bio-Rad Laboratories, Inc.

8.8 Thermo Fisher Scientific, Inc.

8.9 LI-COR, Inc.

8.10 EMD Millipore

8.11 Sigma Aldrich Corporation

Browse Full Report @ http://www.hexareports.com/report/biochip-market/details


Biochip market insights analysis and segment forecasts to 2024 hexa reports

Hexa Reports

Market Research Reports and Insightful Company Profiles

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom

research and consulting services to a host of key industries across the globe. We offer comprehensive

business intelligence in the form of industry reports which help our clients obtain clarity about their

business environment and enable them to undertake strategic growth initiatives.

Contact Information:

Ryan Shaw

Felton Office Plaza,

6265 Highway 9,

Felton, California, 95018,

United States

Phone Number

1-800-489-3075

Email Us: [email protected]

Our Website: http://www.hexareports.com/

Visit our Blog: http://hexareports.blogspot.com/

Like our Facebook page: https://www.facebook.com/hexareportsindustry/

Follow us on LinkedIn: https://www.linkedin.com/company/hexa-reports-inc-


  • Login